You are viewing a limited version of this profile. To access i3's full capabilities.
Paleo
Save
Company logo (jpg or png)
Parent company

Short description

Developer of 'animal-free' heme proteins via precision fermentation, for use as ingredients in alt-protein products

Founded in 2020
Founded in

Company type Private Public ()
Company type

Industry Group agriculture & food

Sector alternative proteins

TRL Range 4-6
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Belgium Leuven, Belgium
Address
City
State
Zip
Country

Parent Companies

Updated by Hattie Partner at on 04/24/2025

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
10/31/2024
Revo Foods Revo Foods
The project has been funded with a total project volume of €2.2M by the European Union. This funding will be used to develop myoglobin for vegan salmon alternatives with Paleo's fermentation technology and Revo Foods' 3D structuring experience.
View source    
Confirmed by Revo Foods
Project Development
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
10/31/2024 European Union European Union (1)
Post-money valuation of
Together with Paleo's partner Revo Foods, the companies will develop myoglobin for vegan salmon alternatives using Paleo's fermentation technology and Revo Foods' 3D structuring experience.
Project Finance $2,394,295
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font